GO:0099050 vesicle scission: Mechanism & Genes

Vesicle scission (GO:0099050) is the terminal membrane-remodeling event that releases a cargo-bearing vesicle from its donor membrane. The Gene Ontology defines it as the membrane scission process that is the final step in vesicle formation, leading to separation from the parent membrane, and notes that it involves constriction of a neck-forming protein complex, consisting e.g. of dynamin, around the budded membrane. This step is mechanistically distinct from cargo selection and membrane bending, and it is often the rate-limiting event that determines whether a transport intermediate is successfully released [1,2]. Scission is not a single universal reaction. In clathrin-mediated endocytosis, dynamin assembles into helical collars at the bud neck and uses GTP hydrolysis to drive constriction and membrane severance [1,2,6]. In endosomal sorting and multivesicular body biogenesis, ESCRT-III filaments and associated ATPases mediate membrane fission from the cytoplasmic face [5,7]. In mitochondria, DRP1 together with MIRO proteins drives the formation of mitochondrial-derived vesicles, a quality-control scission process. More recently, biomolecular condensates have been shown to bend and scission endosome membranes, expanding the mechanistic repertoire beyond classical protein machines. For researchers, vesicle scission is a convergence point for cell biology, neuroscience, and cancer biology. Because scission proteins are genetically tractable and visually assayable, they are frequent targets for CRISPR-based perturbation and high-content imaging screens [1,2,5]. Understanding which gene drives scission in a given membrane system, and whether that gene is causally required, is a recurring experimental question that motivates the models and methods described below.

In plain terms, vesicle scission is the cutting step that pinches off a vesicle from its parent membrane. According to the QuickGO definition for GO:0099050, it is the membrane scission process that is the final step in the formation of a vesicle, leading to separation from its parent membrane. The definition specifies that vesicle scission involves constriction of a neck-forming protein complex, consisting e.g. of dynamin, around the budded membrane, leading to vesicle closure during its separation from the parent membrane. This places GO:0099050 as a biological_process that is downstream of membrane bending and cargo sorting, and upstream of vesicle uncoating and targeting [1,2].

Vesicle scission is important because it is the decisive step that commits a budded membrane intermediate to becoming a free vesicle. Without scission, cargo remains tethered to the donor membrane and downstream trafficking, signaling, and quality-control pathways stall [1,2]. Because scission is executed by distinct machineries in different organelles, it also provides a node for selective therapeutic and experimental intervention: dynamin-dependent scission dominates endocytic uptake, ESCRT-dependent scission controls receptor downregulation and multivesicular body biogenesis, and DRP1-dependent scission supports mitochondrial quality control [1,3,5]. Consequently, genes encoding scission machinery are recurrently implicated in neurodegeneration, cancer, and trafficking disorders, and they are widely used as CRISPR targets to test causal function [1,2,5].

The following genes and proteins represent the principal scission machineries and their regulatory partners across endocytic, endosomal, and mitochondrial systems.

Vesicle scission is regulated at multiple levels. Dynamin-dependent scission is controlled by GTP binding and hydrolysis, which powers constriction of the neck-forming complex. In endocytosis, coat assembly and curvature-sensing proteins such as BAR-domain proteins coordinate the timing of scission relative to cargo selection [2,6]. ESCRT-III-mediated scission is regulated by the AAA-ATPase VPS4, which disassembles filaments after fission, and by associated factors such as IST1. In mitochondria, DRP1 recruitment to membranes is regulated by adaptor proteins including MIRO1 and MIRO2, which couple scission to mitochondrial quality control. Post-translational modifications and protein-protein interactions further tune scission efficiency, and condensate formation can locally concentrate scission machinery. Together, these regulatory layers ensure that scission occurs at the correct time and place.

Dynamin is the best-characterized scission GTPase, and perturbations in dynamin-dependent scission impair synaptic vesicle recycling and neuronal membrane trafficking. Because neurons depend heavily on clathrin-mediated endocytosis for synaptic function, scission defects can contribute to neurodegeneration [1,2]. ESCRT-III machinery, which mediates endosomal scission, has also been linked to neurodegenerative pathology through impaired membrane remodeling. These connections make scission genes candidate targets for mechanistic studies in neuronal models [1,5].

Scission machinery influences receptor trafficking and signaling, which are frequently dysregulated in cancer [2,5]. ESCRT-mediated scission controls downregulation of surface receptors, and its dysfunction can alter proliferative signaling. Dynamin-dependent endocytosis similarly modulates growth factor receptor turnover [2,6]. Consequently, scission genes are studied as potential modifiers of tumor cell signaling and as targets for functional CRISPR screens [2,5].

DRP1 and MIRO proteins drive mitochondrial-derived vesicle biogenesis, a scission process that supports mitochondrial quality control. When this scission pathway is impaired, damaged mitochondrial components may accumulate, contributing to cellular stress. This makes mitochondrial scission genes relevant to diseases involving mitochondrial dysfunction.

ESCRT-III and associated factors mediate endosomal scission and multivesicular body formation, and their dysfunction disrupts sorting of membrane proteins [5,7]. Hemifusomes and proteolipid nanodroplets have been implicated in multivesicular body formation, highlighting how scission-like remodeling shapes endosomal architecture. Defects in these processes can impair receptor degradation and lysosomal delivery, with broad consequences for cell physiology [5,7].

Live-cell fluorescence imaging with tagged scission proteins allows direct visualization of neck constriction and vesicle release [1,2]. Tagged knock-in lines expressing fluorescent dynamin or ESCRT-III subunits enable tracking of scission dynamics in real time [2,5]. High-content imaging can quantify scission frequency across genetic perturbations.

Affinity purification and mass spectrometry of scission machinery can identify interacting partners and regulatory factors. Proteomic profiling of ESCRT-III complexes has clarified subunit composition and disassembly factors. Similar approaches can map dynamin and DRP1 interactomes [1,3].

Genome-wide CRISPR knockout libraries can be screened for genes whose loss alters scission-dependent trafficking phenotypes [2,5]. Such screens have been used to identify endocytic and endosomal regulators. Hit validation typically combines imaging and biochemical assays.

Reconstitution assays with purified dynamin or ESCRT-III on synthetic membranes test whether a factor is sufficient for scission [1,5]. These assays can dissect GTP hydrolysis requirements and membrane composition dependencies. Condensate-driven scission can also be reconstituted to test physical mechanisms.

Researchers studying vesicle scission-related genes often need to determine whether a candidate gene is causally involved in membrane severance or merely correlated with trafficking phenotypes. Establishing causality requires precise genetic perturbation, ideally with isogenic controls and rescue experiments. EDITGENE provides the CRISPR tools and cell models needed to move from candidate gene to validated mechanism in vesicle scission research.

Vesicle scission (GO:0099050) is the decisive membrane-remodeling step that releases a vesicle from its parent membrane, executed by dynamin, ESCRT-III, DRP1/MIRO, and in some contexts by biomolecular condensates [1,3,4,5]. Its centrality to endocytosis, endosomal sorting, multivesicular body formation, and mitochondrial quality control makes it a recurring focus in cell biology and disease research [2,3,5,7]. Because scission is genetically tractable and visually assayable, CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools for establishing causal gene function [1,2,5]. Combining these models with imaging, proteomics, and library screening will continue to clarify how scission is regulated and how its dysfunction contributes to human disease [2,5].